Department of Surgery, Campus Charité Mitte and Campus Virchow-Klinikum, Experimental Surgery and Regenerative Medicine, Charité - Universitätsmedizin Berlin, Germany. Electronic address: https://twitter.com/BenzingChr.
Department of Surgery, Campus Charité Mitte and Campus Virchow-Klinikum, Experimental Surgery and Regenerative Medicine, Charité - Universitätsmedizin Berlin, Germany.
Surgery. 2022 Apr;171(4):859-866. doi: 10.1016/j.surg.2021.08.057. Epub 2022 Feb 2.
The management of complications after major hepatectomy in perihilar cholangiocarcinoma may not always be successful, leading to failure to rescue. The present study seeks to identify independent risk factors for failure to rescue after major hepatectomy in perihilar cholangiocarcinoma.
We retrospectively analyzed the postoperative course of all consecutive patients who underwent major hepatectomy in a curative intent for perihilar cholangiocarcinoma between 2005 and 2019 at our department. A multivariate logistic regression analysis was performed to identify independent risk factors for failure to rescue.
Of 287 patients, 186 (65%) had major complications (Dindo-Clavien grade ≥IIIa), of which 142 (76%) were grade IIIa to IVb (rescue group). Failure to rescue (FTR group, Dindo-Clavien grade V) occurred in 44 of 186 patients (24%). Age >65 years (odds ratio = 4.001, 95% confidence interval 1.025-15.615, P = .046) and right-sided resection (odds ratio = 17.040, 95% confidence interval 1.926 - 150.782, P = .011) were independently associated with failure to rescue. Preoperative carbohydrate antigen 19-9 levels >100 kU/mL as well as preoperative chemotherapy appear to increase odds for failure to rescue as well; however, the association was short of statistical significance (P = .070 and .079, respectively).
Elderly patients as well as patients undergoing right-sided hepatectomy for perihilar cholangiocarcinoma with high preoperative carbohydrate antigen 19-9 levels are at high risk for failure to rescue. Thus, patients should be assessed critically preoperatively. Postoperatively, close monitoring, especially of patients who are at risk, is mandatory.
肝门部胆管癌根治性肝切除术后并发症的处理并非总能成功,有时甚至会导致治疗失败。本研究旨在确定肝门部胆管癌根治性肝切除术后治疗失败的独立危险因素。
回顾性分析了 2005 年至 2019 年期间在我院接受根治性肝切除治疗肝门部胆管癌的连续患者的术后病程。采用多变量 logistic 回归分析确定治疗失败的独立危险因素。
在 287 例患者中,186 例(65%)发生了重大并发症(Dindo-Clavien 分级≥IIIa),其中 142 例(76%)为 IIIa 至 IVb 级(抢救组)。186 例中有 44 例(24%)发生治疗失败(FTR 组,Dindo-Clavien 分级 V)。年龄>65 岁(比值比=4.001,95%置信区间 1.025-15.615,P=0.046)和右半肝切除(比值比=17.040,95%置信区间 1.926-150.782,P=0.011)与治疗失败独立相关。术前 CA19-9 水平>100 kU/mL 以及术前化疗似乎也增加了治疗失败的几率,但差异无统计学意义(分别为 P=0.070 和 P=0.079)。
对于术前 CA19-9 水平较高的老年患者和接受右半肝切除的肝门部胆管癌患者,治疗失败的风险较高。因此,术前应仔细评估患者。术后,尤其是对高危患者,必须密切监测。